long term effects of glp 1 agonists Psychological and behavioral GLP-1 and GIP in weight loss: a comprehensive review | Journal of Diabetes & Metabolic Disorders Updated Ranking and Side Effects
Description
GLP-1-directed NMDA receptor antagonism for obesity treatment
doi: 10.1136/BJOPHTHALMOL-2021-319232 77 SharmaAMariamAZacherleEMilinovichABaumanJSuganoDSet al
The USA shows growth at 5.2%, reflecting a mature healthcare market but strong demand for advanced treatments
Additionally, new research indicates that tirzepatide potentially has some advantages over traditional metabolic regulation, such as insulin sensitivity improvement and anti-inflammatory effect [2]
Diabetes-related cognitive impairment is divided into three stages: diabetes-associated cognitive decrements, mild cognitive impairment (MCI), and dementia
